Business
Currency:INR
2025/Q3
Stock NameRevenueRatio
Pharmaceuticals67.78B95.83%
New Ventures3.41B4.83%
Inter segment revenue-461.7M-0.65%
Region
Currency:INR
2024/FY
Stock NameRevenueRatio
India108.73B42.19%
United States of America75.02B29.10%
Rest of the World49.69B19.28%
South Africa24.31B9.43%